Life Sciences companies accounting tax life sciences biotech

Catalyst is a publication of Amper's Life Sciences Group.

In this month's publication...

We profile NexMed, a New Jersey based bio-tech company, whose proprietary drug delivery technology will be treating female sexual dysfunction and male sexual dysfunction.

We take a closer look at the compliance transparency rules of how products are advertised to the pharmaceutical medical community.

Explore how the IRS is shifting its focus from pharmaceutical companies to bio-tech companies, and how new tax rules of licensing fees received are changing the life sciences landscape

Dennis Yablonsky of Pennsylvania's Department of Community and Economic Development discusses Pennsylvania's efforts to attract technology businesses

We examine how insurance has become a profitable investment opportunity, and if product liability can be considered an attractive underwriting line, given the litigation environment.






	Contact Us Locations search

December 2007 Issue - Articles

Life Sciences Practice

Welcome to Catalyst

All Roads Lead to Transparency...

Local Solutions to Local Problems

Product Liability Trends in the Insurance Market

Focus on Biotech and Pharma Collaboration Pacts

The Keystone State — A Fertile Breeding Ground for Tech-Based Business

January 2007 Issue - Articles

Other Publications

The Review

HealthLine

TechLine

TaxLine

Law Management Journal

Subscribe to our mailing list to receive our publications by mail and/or email. Sign up today.

Print this article

View as PDF
Send us your comments

Catalyst December 2007

Welcome to Catalyst

John Pennett
Officer-in-Charge, Life Sciences Group
Amper, Politziner & Mattia, PC

Welcome to our second edition of Catalyst. Our first issue received strong feedback for focusing on the business practices relevant to the industry - not just accounting related topics. We are going to keep that focus, bringing an awareness of accounting topics for sure—but also highlighting business trends and topics that we hope will be of interest to a wider audience. Certainly this year's BIO2007 conference brought a lot of interesting and thought provoking topics.

John Pennett
Officer-in-Charge, Life Sciences Group
Amper, Politziner & Mattia, PC

This issue features a profile on NexMed, Inc., an East Windsor-based bio-tech company with some promising product opportunities in its portfolio. Like many emerging public companies in this sector, it has gone through the peaks and valleys - and currently is climbing! Amper, Politziner & Mattia is proud to have NexMed as a client.

We also focus on two other major topics of interest to many companies. The first is a discussion of the compliance “transparency laws”—the rules and requirements of advertising pharmaceutical products to the medical community. We have some outstanding subject matter experts discussing the legal, tracking and reporting requirements of this often overlooked and ever-changing topic.

Next is a discussion on the new tax rules associated with licensing fees received. As this is a major strategy for many bio-tech companies, the taxability of these payments is a significant source of concern, especially as analyses of net operating losses often yield to the conclusion that there are insufficient losses available to offset large non-recurring taxable income events. We also weave some of the complex accounting rules into this discussion.

Dennis Yablonsky, secretary of Pennsylvania’s Department of Community and Economic Development, shares his thoughts on the Keystone State’s efforts to lure and keep high tech businesses and grow the region’s economy.

Finally, we provide an update on global product-liability insurance trends thanks to our friends at Hays Company.

Our next edition will focus on international issues, including a feature on BioPortUSA, a new organization designed to provide turnkey solutions to foreign life sciences companies seeking to establish U.S.-based operations. Amper Politziner & Mattia is proud to be one of the founding partners in this initiative.

Thanks again to our friends at the New Jersey Technology Council for their continued support of this publication. I hope you find it informative and interesting. Please feel free to contact me or a member of the Life Sciences Team at Amper with any comments or suggestions for future articles.

web site design and online marketing solutions
by Set Now Solutions, LLC